UPC APP 36985/2025

—·EP2377536: Methods of Using Sustained Release Aminopyridine Compositions

Case details: Status
—
Action
Procedural application
Category
Other Procedural
Parties: Claimants
Merz Therapeutics GmbH
Merz Pharmaceuticals LLC
Merz Pharma France
Reps: Laëtitia Bénard
Respondents
Viatris Santé
Reps: Marc Lauzeral
Division: Paris LD
Judges: Camille Lignieres · Presiding judge and judge-rapporteur
Carine Gillet · Legally qualified judge
Samuel Granata · Legally qualified judge
Rainer Friedrich · Technically qualified judge
Technology: Pharmaceutical & Medical
Language: —
First decided: Sep 17, 2025

Decisions

2025-09-17
Generic application
Paris Local Division order (judge-rapporteur Lignières, full panel) in provisional measures proceedings by Merz Therapeutics GmbH and related Merz entities against Viatris Santé concerning EP 2 377 536 (botulinum toxin / SPC FR13C0033). The order addresses Merz's procedural application (R. 9 RoP) to limit or restructure Viatris' 473-page objection, or alternatively to set a page limit for subsequent submissions. No substantive ruling on the provisional measures application.
Legal issues:Provisional measures procedural application (R. 9 RoP)Page limit for pleadingsBotulinum toxin / SPC patent

Documents